AKT2

AKT2

AKT2, also known as protein kinase B beta (PKBβ), is a serine/threonine-specific protein kinase that plays a critical role in various cellular processes, including glucose metabolism, cell proliferation, apoptosis, transcription, and cell migration. It is one of the three isoforms of the AKT kinase family, the others being AKT1 and AKT3.

Structure

AKT2 is encoded by the AKT2 gene located on chromosome 19q13.1-q13.2. The protein consists of three main domains:

• Pleckstrin Homology (PH) Domain: This domain is responsible for binding phosphoinositides, which localizes AKT2 to the plasma membrane.
• Kinase Domain: The central domain that possesses the catalytic activity of the enzyme.
• Regulatory Domain: The C-terminal domain involved in the regulation of kinase activity.

Function

AKT2 is primarily involved in the insulin signaling pathway. It plays a pivotal role in the regulation of glucose uptake by facilitating the translocation of GLUT4 glucose transporters to the cell membrane in response to insulin. This function is crucial for maintaining normal blood glucose levels.

AKT2 also influences other cellular processes such as:

• Cell Survival: By phosphorylating and inactivating components of the apoptotic machinery, AKT2 promotes cell survival.
• Protein Synthesis: It activates mTORC1, a key regulator of protein synthesis.
• Cell Cycle Progression: AKT2 can phosphorylate and regulate proteins involved in cell cycle progression, such as p21 and p27.

Clinical Significance

Mutations and dysregulation of AKT2 have been implicated in various diseases, including:

• Cancer: Overexpression or amplification of AKT2 is observed in several cancers, such as ovarian, pancreatic, and breast cancer. It contributes to tumorigenesis by promoting cell survival and growth.
• Diabetes: Given its role in insulin signaling, AKT2 dysfunction can lead to insulin resistance, a hallmark of type 2 diabetes.

Research and Therapeutic Targeting

AKT2 is a target for therapeutic intervention in diseases where it is dysregulated. Inhibitors of AKT2 are being explored for their potential in cancer therapy. Understanding the specific roles of AKT2 in different tissues and conditions is crucial for developing targeted therapies.

Also see

• AKT1
• AKT3
• Insulin signaling pathway
• Protein kinase
• Cancer
• Diabetes mellitus type 2